-Reuters citing CNN interview
SVB Leerink Downgrades ContraFect to Market Perform, Lowers Price Target to $1
SVB Leerink analyst Roanna Ruiz downgrades ContraFect (NASDAQ:CFRX) from Outperform to Market Perform and lowers the price target from $9 to $1.